ImmusanT
A biotechnology company developing therapies and personalized diagnostics for celiac disease
3
Funding Rounds
$60.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Le**** Wi****** (e************ | - | - | - |
Funding
Funding series
Funding Series Analysis
The company ImmusanT has raised a total of $60m in funding over 3 rounds.
Key Insights:
- ImmusanT Series C round, November 2017: $40m
- ImmusanT Series A round: $20m
ImmusanT Series C round, November 2017
$40m
ImmusanT Series A round
$20m
Industries
ImmusanT is active in the following industries: